Neoadjuvant chemotherapy with Cabazitaxel in high risk prostate cancer patients prior to radical prostatectomy Neoadjuvante Chemotherapie mit Cabazitaxel vor der radikalen Prostatektomie

| Pays :
| Organes :
| Spécialités :

Extrait

The primary goal of this trial is to define the pathologic complete response rate of cabazitaxel chemotherapy in patients with untreated, high-risk localized prostate cancer.

Critère d'inclusion

high-risk prostata cancer patients

Liens

ictrp
euctr